Furthermore, in NASH patients the expression of PNPLA3 significantly correlated with fibrosis stage and alpha-smooth muscle actin (α-SMA) levels thus suggesting that its metabolic regulation differs among hepatocytes and HSCs [18]. This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatohepatitis.